150 related articles for article (PubMed ID: 34750958)
21. Utility of Multiparametric Magnetic Resonance Imaging With PI-RADS, Version 2, in Patients With Prostate Cancer Eligible for Active Surveillance: Which Radiologic Characteristics Can Predict Unfavorable Disease?
Kim H; Pak S; Park KJ; Kim MH; Kim JK; Kim M; You D; Jeong IG; Song C; Hong JH; Kim CS; Ahn H
Clin Genitourin Cancer; 2020 Feb; 18(1):50-55. PubMed ID: 31640913
[TBL] [Abstract][Full Text] [Related]
22. Development and External Validation of a Multiparametric Magnetic Resonance Imaging and International Society of Urological Pathology Based Add-On Prediction Tool to Identify Prostate Cancer Candidates for Pelvic Lymph Node Dissection.
Draulans C; Everaerts W; Isebaert S; Van Bruwaene S; Gevaert T; Oyen R; Joniau S; Lerut E; De Wever L; Laenen A; Weynand B; Defraene G; Vanhoutte E; De Meerleer G; Haustermans K
J Urol; 2020 Apr; 203(4):713-718. PubMed ID: 31718396
[TBL] [Abstract][Full Text] [Related]
23. Can combined multiparametric magnetic resonance imaging of the prostate and prostate-specific antigen density improve the detection of clinically significant prostate cancer: A prospective single-center cross-sectional study.
Yadav K; Sureka B; Elhence P; Choudhary GR; Pandey H; Garg PK; Yadav T; Khera PS
J Cancer Res Ther; 2021; 17(2):372-378. PubMed ID: 34121679
[TBL] [Abstract][Full Text] [Related]
24. Focusing PSA testing on detection of high-risk prostate cancers by incorporating patient preferences into decision making.
Thompson IM; Leach RJ; Ankerst DP
JAMA; 2014 Sep; 312(10):995-6. PubMed ID: 25090603
[No Abstract] [Full Text] [Related]
25. Men under the age of 55 years with screen detected prostate cancer do not have less significant disease compared to older men in a population of patients in Australia.
Dantanarayana ND; Hossack T; Cozzi P; Brooks A; Lau H; Delprado W; Patel MI
BMC Urol; 2015 Dec; 15():124. PubMed ID: 26715039
[TBL] [Abstract][Full Text] [Related]
26. Findings in 1,123 Men with Preoperative
Raveenthiran S; Yaxley WJ; Franklin T; Coughlin G; Roberts M; Gianduzzo T; Kua B; Samaratunga H; Delahunt B; Egevad L; Wong D; McEwan L; Brown N; Parkinson R; Esler R; Yaxley JW
J Urol; 2022 Mar; 207(3):573-580. PubMed ID: 34694140
[TBL] [Abstract][Full Text] [Related]
27. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies.
Pokorny MR; de Rooij M; Duncan E; Schröder FH; Parkinson R; Barentsz JO; Thompson LC
Eur Urol; 2014 Jul; 66(1):22-9. PubMed ID: 24666839
[TBL] [Abstract][Full Text] [Related]
28. Funding of prostate magnetic resonance imaging leads to fewer biopsies and potential savings to health systems in the management of prostate cancer.
Whish-Wilson T; Costello D; Finch S; Sutherland T; Wong LM
BJU Int; 2021 May; 127 Suppl 1():6-12. PubMed ID: 33025681
[TBL] [Abstract][Full Text] [Related]
29. [PSA volume quotient: an additional parameter in diagnosis of locally confined prostate cancer].
Gottfried HW; Kleinschmidt K; Flohr P; Miller K; Hautmann R
Urologe A; 1993 Nov; 32(6):455-9. PubMed ID: 7506850
[TBL] [Abstract][Full Text] [Related]
30. Value of Serial Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Imaging-guided Biopsies in Men with Low-risk Prostate Cancer on Active Surveillance After 1 Yr Follow-up.
Hamoen EHJ; Hoeks CMA; Somford DM; van Oort IM; Vergunst H; Oddens JR; Smits GA; Bokhorst LP; Witjes JA; Rovers MM; Hulsbergen-van de Kaa CA; Barentsz JO
Eur Urol Focus; 2019 May; 5(3):407-415. PubMed ID: 29331622
[TBL] [Abstract][Full Text] [Related]
31. The Impact of Histopathological Features of Prostate Cancerous Lesions on Multiparametric Magnetic Resonance Imaging Findings using PI-RADS Version 2.
Naito H; Kato T; Ishikawa R; Tanaka K; Ueda N; Matsuoka Y; Miyauchi Y; Taoka R; Tsunemori H; Haba R; Nishiyama Y; Sugimoto M; Kakehi Y
Urology; 2021 Mar; 149():174-180. PubMed ID: 33285212
[TBL] [Abstract][Full Text] [Related]
32. Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 Men.
Catalona WJ; Richie JP; Ahmann FR; Hudson MA; Scardino PT; Flanigan RC; DeKernion JB; Ratliff TL; Kavoussi LR; Dalkin BL; Waters WB; MacFarlane MT; Southwick PC
J Urol; 2017 Feb; 197(2S):S200-S207. PubMed ID: 28012755
[TBL] [Abstract][Full Text] [Related]
33. Risk Factors for Biopsy Reclassification over Time in Men on Active Surveillance for Early Stage Prostate Cancer.
Lonergan PE; Washington SL; Cowan JE; Zhao S; Nguyen HG; Shinohara K; Cooperberg MR; Carroll PR
J Urol; 2020 Dec; 204(6):1216-1221. PubMed ID: 32519915
[TBL] [Abstract][Full Text] [Related]
34. Early-stage prostate cancer, PSA screening rates decline.
Printz C
Cancer; 2016 Mar; 122(6):825. PubMed ID: 26938268
[No Abstract] [Full Text] [Related]
35. Use of Prostate Specific Antigen Density Combined with Multiparametric Magnetic Resonance Imaging Improves Triage for Prostate Biopsy.
Záleský M; Stejskal J; Adamcova V; Hrbáček J; Minarik I; Pavlicko A; Votrubova J; Babjuk M; Zachoval R
Urol Int; 2019; 103(1):33-40. PubMed ID: 31067560
[TBL] [Abstract][Full Text] [Related]
36. [Diagnostic possibilities of prostate biopsy].
Pushkar' DIu; Govorov AV
Urologiia; 2002; (6):46-51. PubMed ID: 12577581
[No Abstract] [Full Text] [Related]
37. Urban-rural differences in prostate cancer outcomes in Australia: what has changed?
Baade PD; Youlden DR; Coory MD; Gardiner RA; Chambers SK
Med J Aust; 2011 Mar; 194(6):293-6. PubMed ID: 21426283
[TBL] [Abstract][Full Text] [Related]
38. More data on prostatic cancer--how valuable are they?
Fitzpatrick JM
J Urol; 1997 Dec; 158(6):2180-1. PubMed ID: 9366339
[No Abstract] [Full Text] [Related]
39. [Prostatic neoplasms: clinical and biological aspects, histopathologic patterns].
Puech P; Villers A; Mouton D; Leroy X; Lemaître L
J Radiol; 2006 Feb; 87(2 Pt 2):189-200. PubMed ID: 16484944
[TBL] [Abstract][Full Text] [Related]
40. Challenges in Adopting Level 1 Evidence for Multiparametric Magnetic Resonance Imaging as a Biomarker for Prostate Cancer Screening.
Kim SJ; Vickers AJ; Hu JC
JAMA Oncol; 2018 Dec; 4(12):1663-1664. PubMed ID: 30242308
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
